Fred Hutch researchers show in recent study how aggressive prostate cancer shapeshifts from a form that is treatable with ...
Prostate cancer is projected to be the most commonly diagnosed cancer among men in the United States next year, and the updated PSA testing guidelines for 2026 arrive at a pivotal moment for anyone ...
Renaming the lowest-grade prostate cancer to something other than cancer might save men’s lives These GG1 cases do not cause symptoms or become life-threatening unless a higher-grade cancer develops ...
A new test could make it easier to detect high-risk prostate cancer cases earlier. The blood test, called Stockholm3, is showing promise in clinical trials, beating out the traditional, standard ...
Urologic oncologists who treat prostate cancer are split over the benefits of focal therapy compared to traditional surgery ...
Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Although more testing is needed, the drug’s unusual mechanism ...
Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the immune system in preclinical mouse studies. Combined with immunotherapy, the ...
Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. “How long do I have to live ?” When I ...
An updated Cochrane review has found that prostate-specific antigen (PSA) screening probably reduces deaths from prostate cancer — a notable shift from the influential group’s 2013 conclusion that ...
Share on Pinterest A multivariable risk assessment tool may detect more clinically significant prostate cancers than PSA testing alone. Image credit: MoMo Productions/Getty Images In a recent study, ...
High-risk localized and locally advanced prostate cancer patients treated with apalutamide - a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI) - plus hormone therapy before and ...